For research use only. Not for therapeutic Use.
QCP01(CAT: I035303) is a novel imaging agent designed for advanced cancer diagnostics and research. It is engineered to selectively target tumor-specific markers or microenvironments, enabling precise visualization of cancerous tissues. QCP01 enhances imaging contrast, improving the detection of tumors and metastatic sites through techniques like positron emission tomography (PET), magnetic resonance imaging (MRI), or fluorescence imaging. Its high specificity and sensitivity make it a valuable tool in oncology research for monitoring tumor progression, evaluating treatment response, and aiding in the development of targeted cancer therapies.
| Catalog Number | I035303 |
| Synonyms | QCP01; QCP-01; QCP 01; |
| Molecular Formula | C66H75N7O17S4 |
| Purity | 98% |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 1-(6-((3-((4-((2-((S)-2-cyanopyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)amino)-6-oxohexyl)-2-((E)-2-((E)-3-(2-((E)-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)indolin-2-ylidene)ethylidene)-2-(4-sulfophenoxy)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate |
| InChI | InChI=1S/C66H75N7O17S4/c1-65(2)54-40-50(93(83,84)85)24-27-57(54)72(34-7-5-6-16-61(74)69-32-12-37-89-48-21-26-56-53(39-48)52(31-33-68-56)64(76)70-43-62(75)71-36-11-15-46(71)42-67)59(65)29-17-44-13-10-14-45(63(44)90-47-19-22-49(23-20-47)92(80,81)82)18-30-60-66(3,4)55-41-51(94(86,87)88)25-28-58(55)73(60)35-8-9-38-91(77,78)79/h17-31,33,39-41,46H,5-16,32,34-38,43H2,1-4H3,(H5-,69,70,74,76,77,78,79,80,81,82,83,84,85,86,87,88)/t46-/m0/s1 |
| InChIKey | JPMCOMGUYMABHG-DXQCBLCSSA-N |
| SMILES | O=S(C1=CC2=C(C=C1)[N+](CCCCCC(NCCCOC3=CC=C4N=CC=C(C4=C3)C(NCC(N5[C@@H](CCC5)C#N)=O)=O)=O)=C(C2(C)C)/C=C/C6=C(/C(CCC6)=C/C=C7N(C8=C(C/7(C)C)C=C(C=C8)S(=O)(O)=O)CCCCS(=O)(O)=O)OC9=CC=C(C=C9)S(=O)(O)=O)([O-])=O |
